Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 370.78 USD 1.17%
Market Cap: 141.3B USD
Have any thoughts about
Stryker Corp?
Write Note

Stryker Corp
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stryker Corp
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Stryker Corp
NYSE:SYK
PP&E Gross
$3.9B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
14%
Becton Dickinson and Co
NYSE:BDX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
PP&E Gross
$3.5B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
9%
Edwards Lifesciences Corp
NYSE:EW
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
PP&E Gross
$10.6B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
PP&E Gross
$4.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stryker Corp
Glance View

Market Cap
141.3B USD
Industry
Health Care
Economic Moat
Wide

Stryker Corporation, a pioneering force in the medical technology industry, traces its roots back to the innovative spirit of Dr. Homer Stryker, an orthopedic surgeon whose dissatisfaction with existing medical equipment spurred him to improve them. Founded in 1941, the company initially focused on new medical devices that addressed specific problems faced by healthcare practitioners. Over the decades, Stryker has evolved into a diversified powerhouse with a portfolio that spans a wide range of products, including joint replacements, surgical equipment, neurotechnology, and spine care solutions. This evolution came through strategic acquisitions and relentless innovation, allowing Stryker to meet the ever-increasing demands of a dynamic healthcare landscape. The company's business model thrives at the intersection of technology and healthcare. With their cutting-edge research and development capabilities, Stryker consistently pushes the envelope in creating sophisticated products that enhance patient outcomes. Revenue streams are predominantly generated from the sale of medical and surgical equipment as well as a myriad of implantable surgical devices used in orthopedic procedures. Stryker’s instruments and solutions are staples in hospitals and clinics worldwide, driven by their commitment to quality and efficacy. Additionally, the company's astute investments in advanced robotics and digital health technologies have positioned it well within the burgeoning field of precision medicine, providing lucrative opportunities to deepen its market entrenchment and expand its competitive edge.

SYK Intrinsic Value
286.97 USD
Overvaluation 23%
Intrinsic Value
Price

See Also

What is Stryker Corp's PP&E Gross?
PP&E Gross
3.9B USD

Based on the financial report for Sep 30, 2024, Stryker Corp's PP&E Gross amounts to 3.9B USD.

What is Stryker Corp's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
14%

Over the last year, the PP&E Gross growth was 10%. The average annual PP&E Gross growth rates for Stryker Corp have been 8% over the past three years , 7% over the past five years , and 14% over the past ten years .

Back to Top